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outside the milieu of the erythrocyte with its allosteric effecPeriodate-oxidized adenosine triphosphate
(0-ATP),
a ribose ring-opened dialdehyde derivative of ATP, tors. Other bifunctional reagents with high affinity for the
reacts specifically with human deoxyhemoglobinto organic phosphate-binding site have been shown to produce
give a single major covalently modifiedproduct after interdimerically (ap-pa)cross-linked derivatives with signifreduction with sodium borohydride. This product, desicantly decreased oxygen affinity; for example, 2-nor-2-forignated di-ATP H b , was isolated using ion-exchange mylpyridoxyl-5'-phosphate (7), and 4,4'-diisothiocyanostiichromatography and shownto have incorporatedtwo bene-2,2'-disulfonate (DIDS) (8).However, it has been shown
molecules of0-ATP/tetrarqr. Peptide mapping and
x- that cross-linkedproducts derived from the reaction of human
ray crystallography at
2.8-A resolution indicate that
a deoxyhemoglobin with o-ATP exhibitincreased oxygen affincovalent adductis formed between the ligand and
residues Lys-82 EF6 of each/3 chain in the organic phos- ity, presumably due to differing structural constraints introHb exhibits duced by intersubunit cross-linking with this affinity ligand
phate-binding site of the molecule. di-ATP
a significantly decreased oxygen affinity (P60= 20.8 (6). Here we report on the structural and functional characmmHg uersus 5.8 mmHg control; 50 mM 2-[bis(2- terization of a non-cross-linked product of the reaction of
hydroxyethyl)amino]-2-(hydroxymethyl)-propane- human deoxyhemoglobin with o-ATP which has undergone a
1,3-diol, pH 7.4, 0.1 M C, 20 "C). The subunit cooper- monofunctional substitution leading to lowered oxygenaffinativity of di-ATP Hb is also reduced (nmax
= 1.9 versus ity and subunitcooperativity.
2.7 control).
EXPERIMENTALPROCEDURES

o-ATP Synthesis-Adenosine triphosphate and sodium periodate
were obtained from Sigma. o-ATP was synthesized according to the
Adenosine triphosphate (ATP) exhibits a high affinity for procedure of Easterbrook-Smith et al. (2). Reaction yields were monthe organic phosphate-binding siteof human hemoglobin and itored by thin layer chromatography on polyethyleneimine-cellulose
plates (E. Merck, Darmstadt, W. Germany) developed with 0.8 M
affects oxygen affinity in a manner similar to 2,3-diphospho- NH4HC03using UV detection. The o-ATP was purified by chromaglycerate (1).Periodate-oxidized ATP (0-ATP)' is a ribose tography on a Sephadex G-10 column equilibrated with deionized
ring-opened dialdehyde ATP analog (Fig. 1) which has been water at 4 "C. Aliquots were stored at -70 "C and protected from
shown to act as an affinity label for several enzymes which light.
Reaction of Hemoglobin with o-ATP-Hemoglobin A was isolated
use ATP as a substrate(2,3). Because o-ATP is bifunctional,
it has thecapacity for introducing intermolecular cross-link- from freshly drawn human blood according to methods previously
ages through Schiff base formation with free amino groups. described (9). Thehemoglobin wasdeoxygenated prior to reaction by
flushing a solution in a round bottom flask on a rotary apparatus
The organic phosphate-binding site of human hemoglobin is with nitrogen for 3 h at 0 "C. Hemoglobin concentration was 0.25 mM
situated at the interface of the two p chains in the central in 50 mM Tris, pH 7.8. Degassed o-ATP solution was introduced
cavity of the molecule andcontains four primary amino anaerobically to give a final concentration of 0.275 mM. Degassed
groups, Lys-82 EF6 and Val 1 NA1 from p1 and p2. Because sodium borohydride (10 mM) was added 30 min after addition of oATP. The reaction was stopped by chromatography on a G-25 Sephof its unique chemistry, o-ATP has been used to attempt
structural andfunctional modification of hemoglobin in order adex column equilibrated with 50 mM Tris, pH 7.8. Modified hemoto produce a cross-linked, low oxygenaffinity derivative which globin was purified by preparative ion-exchange chromatography on
CM-Sephadex with a gradient consisting of 50 mM bis-Tris run from
might be suitable for use as a cell-free blood substitute (4-6). pH 6.7 to 7.2
Such structural and functional modifications would address
HPLC of Hemoglobins and Peptides-Yields of modified hemoglotwo of the major problems associated with infusion of native bin were determined by HPLC on acation exchange column (PolycatHb solution as an acellular blood substitute, i e . rapid renal A, Custom LC Inc., Houston, TX) (10) monitored a t 419 nm using
clearance of dissociated cup dimers and high oxygen affinity an IBM System 9000 for peak integration. Separationof globin chains
was accomplished by reversed-phase HPLC on a Vydac C, column
* This work wassupported by United States Public Health Service (The Separations Group, Hesperia, CA), monitoring a t 220 nm (11).
Grants HL-20142 and AM-17850 and by a Tartar Fellowship from Tryptic peptide separation was performed on a Vydac Cla large-pore
the Medical Research Council of Oregon (to M. P. K.). The costs of reversed-phase column following a modification of the method of
publication of this article were defrayed in part by the payment of Shelton et al. (12) using a gradient between 0.1% trifluoroacetic acid
page charges. This article must therefore be hereby marked "aduer- (A) and 0.1% trifluoroacetic acid in acetonitrile (B). Thegradient ran
tisement" in accordance with 18U.S.C. Section 1734 solelyto indicate from 0 to 13.6% B in 20 min, then to34% B in 50 min, then to100%
B in 5 min, a t a flow rate of 1 ml/min.
this fact.
Proteolytic Digestion-Trypsin (Worthington) was added to aceThe abbreviations used are: o-ATP, periodate-oxidized ATP,
DIDS, 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid; bis-Tris, 2- tamidated, heat-denatured Hb (1:50, w/w) and incubated for 8 h at
[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)-propane-1,3-diol;37 "C in 80 mM NH4C03, pH 8.5 Hb (nativeor modified) was
HPLC, high pressure liquid chromatography.
acetamidated at p-93 Cys in order to solubilize tryptic peptide at-10
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FIG. 1. Postulated structure of periodate-oxidized adenosine triphosphate (Ref. 2).
following a modification of the procedure of Goldstein et al. (13).
Oxyhemoglobin (0.5 mM)was reacted with iodoacetamide (10 mM)
for 2 h at 20 "C in 10 mM potassium phosphate, pH 7.0, and protected
from light. The reaction was halted by chromatography on a column
of Sephadex G-25.
Gel Electrophoresis-Separation of cross-linked globin from monomer was accomplished by electrophoresis in a 12% discontinuous
polyacrylamide gel in the presence of sodium dodecyl sulfate and
mercaptoethanol (14).
Functional Testing-Oxygen equilibrium curves were determined
a t a hemoglobin concentration of 15 pM in 50 mM bis-Tris buffer, pH
7.4,O.l M C1-, at 20 "C, using an automated recording apparatus (15).
A Cary 219 spectrophotometer and a polarographic oxygen electrode
(Beckman Instruments 39065) were employed. Data aquisition and
reduction were performed with a PDP 11/V03 computer (Digital
Equipment Corp.) (16).
X-ray Crystallography-Di-ATP Hb was crystallized in the deoxy
form according to Perutz (17). Friedel pairs of about 14,000reflections
extending to 2.8-A resolution were collected from one crystal on a
Hilger four-circle diffractometer. The data were corrected by the
usual factors and scaled against the native data (21). The R-factor
between Friedel pairs was 3.7% on intensity, that between derivative
and native data was 6.5% on amplitude. An electron density difference
map (&-ATP minus native deoxyhemoglobin) was calculated with
phases from the native model (21). The map was contoured at rt0.06
e/A3, or approximately rt3 times the root mean square density over
the whole cell (0.19 e/AS).

RESULTS AND DISCUSSION

Separation of o-ATP-modified Derivatives-After reacting
deoxyhemoglobin with o-ATP followedby reduction with
sodium borohydride, the reaction mixture was chromatographed by cation-exchange HPLC (Fig. 2). The elution profileshows the appearance of one major reaction product
eluting at 16.2 min. In addition, several minor peaks appear
which elute in positions intermediate between HbA and the
major reaction product. These minor peaks include products
containing intersubunit cross-linkages which exhibit increased oxygen affinity (6). The major peak eluting at 16.2
min was preparatively purified by ion-exchange chromatography on CM-Sephadex with a pH gradient of 50 mM bisTris, pH 6.7-7.2. Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis of this modified hemoglobin revealed that it
contained no intersubunit cross-linkages (data not shown).
Because o-ATP has a large extinction coefficient at 259 nm,
it was possible to obtain an estimate of the number of molecules of o-ATP associated with the modified hemoglobin by
spectroscopy (TableI). The
of25.5 mM" corresponded
to 1.7 molecules of o-ATP bound per tetramer, suggesting
that the product was disubstituted. This product, designated
di-ATP Hb, was produced consistently in a yield of 40-50%
as determined by peak integration following cation-exchange
HPLC. Although the molar ratio of o-ATP to hemoglobin
tetramer was 1.1:l in the reaction mixture, the maximum
yield of di-ATP Hb observed was 50%.Increasing the reagent
to Hb ratio to 2.2:l did not result in any further increase in
yield of di-ATP Hb. When the ratio of reagent to tetramer
was further increased to lO:l, there was a marked increase in
the extent of modification; this was apparently due to heterogenous nonspecific reactions as evidenced by numerous new
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FIG. 2. Cation-exchange HPLC of crude reaction mixture
following reaction of deoxyhemoglobin with o-ATP. Gradient
and conditions are described under "Experimental Procedures."

TABLEI
Extinction coefficientsat 259 nm (A,- o-ATP) for native and o-ATP
modified hemoglobins
Concentration of hemoglobins was determined for the cyanmet
form on the basis of t510= 44 mM" cm" (19). For o-ATP, €259 = 14.9
mM"cm"
(2).
Native (CN-Met) 0.264 (6.00 p M ) 0.618
di-ATP (CN-Met) 0.269 (6.11 p M ) 0.785

103.0
128.5

0

25.5

peaks appearing during cation-exchange HPLC(datanot
shown). One possible mechanism to account for the observed
50% limit in yield of di-ATP Hbinvolves the dissociation and
reassociation of hybrid species which can takeplace following
oxygenation during ion-exchange chromatography. In order
for affinity labeling to take place, specific binding must occur
followed by covalent bond formation. It has been shown that
only one molecule of the organic phosphate 2,3-diphosphoglycerate binds to the PIPzcleft of deoxyhemoglobin (18).
Even more steric hindrance would be expected in the case of
o-ATP for a second molecule binding to the cleft after a first
molecule has bound. Thus, aninitial specific reaction of each
deoxyhemoglobin tetramer with one molecule of o-ATP, followed bysubunit dissociation and reassociation upon oxygenation and ion-exchange chromatography would give rise to
the following equilibrium.
2

a2ppATP c-*

2 ap

+2

,@ATP

c-*

ad32

+

a28fTP

Such a mechanism would lead to a yield of di-ATP Hb with
an upper limit of 50%. In order to confirm this mechanism,
however, further studies using anaerobic ion-exchange chro-
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matography in order to trap hybrid molecules in the deoxy
state will be required.
Tryptic Peptide Mapping-In order to determine the sites
of modification by o-ATP, ion-exchange purified HbA and diATP Hb were iodoacetamidated, heat denatured, and subjected to trypsin digestion. After trypsin treatment for 8 h at
37 "C, the tryptic hydrolysates were chromatographed by reversed-phase HPLC. The a-globin tryptic peptides derived
from di-ATP Hb were identical to those of native a-globin.
In contrast, the tryptic map of @-globintryptic peptides from
di-ATP Hbrevealed the absence of the adjacent tryptic peptides Bt-9 and fib10 (Fig. 3). In native @-globin,tryptic pep0.1
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tides fit-9and @t-10 are split as result
a
of enzymatic hydrolysis at Lys-82 EF6, a residue found in the @& cleft which
plays an important role in binding organic phosphates
through ionic interactions (18).The absence of @t-9 and@t10 suggests that reductive alkylation of the t-amino group of
Lys-82 EF6 by o-ATP had occurred, inhibiting tryptic cleavage at this site and resulting in the formation of a larger,
presumably insoluble peptide. As wouldbe expected, the
tryptic fragment pt-10, 11, which in native Hb hydrolysates
is normally present in variable yield due to incomplete cleavage, was also missing from the di-ATP Hb hydrolysate. No
other changes in the peptide pattern were observed. These
resultssupport the conclusion from spectroscopic studies
indicating that the protein is disubstituted, as both fi chains
have been modified and theprotein is not cross-linked.
X-ray Crystallography-The electron density difference
map of deoxy &-ATPHb minus HbA obtained at 2.8-A
resolution is shown in Figs. 4 and 5. The most prominent
features in the map are the symmetric positive double peaks
in the central cavity between the two Lys-82 EF6 (Fig. 4).
The 0-ATP molecules can be fitted into thesepeaks with the
Lys-82 EF6 t-amino adduct as either a bifunctional morphomonofunctional
lino derivative (Fig. 5, aand b ) orasa
secondary amine involving a ?ingle aldehyde from C3' of oATP (Fig. 5,c and d ) . At 2.8-A resolution it is not possible to
distinguish between these two possibilities, although the morpholino configuration appears to give a slightly better fit. In
any case it is clear from the map that the adenine rings take
up a parallel "stacked configuration approximately 3.5
apart. The map also shows a prominent peak centered near
the site of Asn-139 H17. Since the atoms of this side chain
have high temperature factors in the native structure, this
peak probably represents a reduction of the Asn mobility due
to its being trapped between the ligand and the H helix. The
negative peaks between the positive peaks discussed above
probably result from the exclusion of water. Small negative
peaks on the cavity side of helix H, near position H12, and
even smaller positive ones away from the cavity near H10 and
H15 suggest a slight opening of the cavity by o-ATP. Positive
and negative peaks surrounding the side chain of His-143
H21 indicate that this group moves toward the ATP and
interacts either with the phosphate or with the 3' hydroxyl
in the morpholino configuration. The exact position of the
phosphate is not well determined in the map. It may interact
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FIG.3. CISHPLC tryptic peptide maps of iodoacetamidated
HbA (top)and di-ATP Hb (bottom).Arrows indicate positions of
tryptic peptides Pt-9, @lo, and @t-lO,ll
which are missing from the
di-ATP Hb hydrolysate.

FIG.4. The
difference
map
deoxy-di-ATP Hb minus HbA showing the region of the o-ATP-binding
site. Solid contours, +0.06 e/A3; dashed
contours, -0.06 e/A3. The atomic model
is of native deoxy-HbA. There were no
significant features inthe difference map
outside of the region illustrated.
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Phos-3

FIG. 5. Detailed view of o-ATP
bound to Lys-82 EF6 either bifunctionally (aand b ) or monofunctionally at C3' only (c and d ) . Parts a and
c show the fit to thedifference map; solid
contours: +0.06 e/A3; dashed contours:
-0.06 e/A3; intermediate bonds: native
model with the side chain of Asn-139
HI7 shifted according to the difference
map; lightest bonds: symmetry-related oATP. Parts b and d show the binding in
more detail, with bonded atoms labeled.
The viewpoint is the same in all four
parts of the figure.

Structure and Function of 0-ATP Hb

b

Phos-3

C L

R
Ph

Ph

d

L

R

Structure and Function of o-ATP Hb

loo
so
~~

r
0
.-

g3

r"l

60
40

0
"
20

0
.1

1

10

100

1000

PO* (mm

FIG. 6. Oxygen equilibrium curves of HbA (squares)and diATP Hb (triangzes).Recordings were performedin 50 mM bis-Tris,
pH 7.4, 0.1 M c1-,20 "c.Hb concentration was 15 pM tetramer.

also with His-2 NA2 or the a-aminoterminus of the (3 chain,
but the map shows no evidence of movement or localization
of these groups. (The periodic progression of positive and
negative peaks across the central cavity might suggest an
artifact due to gross mis-measurement of a single reflection.
In order to test this possibility, a difference map was calculated omitting all75 reflections with AF greater than theroot
mean square of A F . The difference maps calculated with and
without these large AF values were virtually identical, ruling
out thepossibility of such an artifact.)
Functional Testing of o-ATP-modified Hb-Fig. 6 shows a
comparison of the oxygen equilibrium curves for HbA and diATP Hb. Under the conditions tested (50 mM bis-Tris, pH
7.4,0.1 M C1-,20 "C), the Pmof di-ATP Hb is significantly
increased relative to HbA (20.8 mm Hg versus 5.8 mm Hg).
In addition, the subunit cooperativity of di-ATP Hb is reduced
= 1.9; control nmax
= 2.7).
Conclusions-It has been demonstrated that o-ATP serves
as anefficient affinity label for the organic phosphate-binding
site of deoxyhemoglobin via adduct formation with p Lys-82
EF6. It is noteworthy that while both affinity ligands o-ATP
and pyridoxal phosphate label the organic phosphate-binding
site, the amino acid residue involved in o-ATP adduct formation is different from that of pyridoxal phosphate, which
has been shown to involve an adduct with B Val-1 NA1 (20).
Because of the lower pK andhence greater nucleophilicity of
the @-aminotermini compared with the €-aminogroup of Lys82 EF6, they are more susceptible to alkylation by carbonyl
attacking groups. The modification of p Lys-82 EF6 by oATP andlack of evidence of any reaction products involving
the amino termini imply a stereochemical binding conformation in the central cavity which would specifically favor reaction with the €-aminogroup,
It has been previously demonstrated that the formation of
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mukiple cross-linked, singly-modified, high-affinity reaction
products from the reaction of 0-ATP with deoxyhemoglobin
can be favored by the use of the milder reducing agent
cyanoborohydride in place of borohydride (6). In contrast,
reduction with borohydride leads to selective formation of the
product described in this work, &-ATP Hb, which exhibits a
significantly lowered oxygen affinity and subunit cooperativity. The structure of the molecule determined by x-ray crystallography suggests a possible mechanism for these functional changes. Both molecules of o-ATP are protruding into
the BIB2cleft with the planes of the adenine rings 3.5 A apart
and parallel to each other. The subunit motion in the EF
regions of the central cavity induced by oxygenation would
tend to push the adenine rings closer together, resulting in
steric repulsion inhibiting the T to R conformational transition. The expected functional effect of this would be a reduction in oxygen affinity due to the shift of the allosteric
equilibrium towards a T-like state. Such a mechanism would
also be consistent with the observed reduction in subunit
cooperativity in di-ATP Hb.
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